Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Highlights the theoretical potential of using human γδ T cells as a cellular vaccine rather than direct effector cells for cancer immunotherapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2014 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: